Babalola C P, Bolaji O O, Ogunbona F A, Dixon P A
Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Ther Drug Monit. 1996 Feb;18(1):30-3. doi: 10.1097/00007691-199602000-00005.
The relationship between saliva and plasma levels of quinine was studied in four healthy volunteers. After a single oral dose of quinine sulfate (600 mg) to the volunteers, quinine was determined in both saliva and plasma simultaneously over a 48-h period by an ion pair reverse-phase high performance liquid chromatography method. The tmax (4.3 +/- 0.5 h) and elimination half-life (11.8 +/- 2.9 h) of quinine derived from saliva levels were comparable with those obtained from plasma levels (tmax = 2.8 +/- 0.2 h, t1/2 = 12.9 +/- 2.3 h). A significant correlation existed between the plasma and saliva concentrations of the drug (r = 0.93, n = 20, p < 0.001). The mean saliva/plasma quinine concentration ratio was 0.24 +/- 0.02. The results suggest that quinine is passively secreted into saliva and that saliva level determination may be useful as a noninvasive method in the evaluation of pharmacokinetic parameters and therapeutic drug monitoring of quinine.
在四名健康志愿者中研究了唾液和血浆中奎宁水平的关系。给志愿者单次口服硫酸奎宁(600毫克)后,采用离子对反相高效液相色谱法在48小时内同时测定唾液和血浆中的奎宁。由唾液水平得出的奎宁的达峰时间(4.3±0.5小时)和消除半衰期(11.8±2.9小时)与从血浆水平获得的结果相当(达峰时间=2.8±0.2小时,半衰期=12.9±2.3小时)。药物的血浆浓度和唾液浓度之间存在显著相关性(r=0.93,n=20,p<0.001)。唾液/血浆奎宁浓度的平均比值为0.24±0.02。结果表明,奎宁被动分泌到唾液中,唾液水平测定作为一种无创方法,在评估奎宁的药代动力学参数和治疗药物监测中可能有用。